Department of Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania
Department of Medicine, University of Melbourne, Melbourne, Victoria, Australia.
J Nucl Med. 2021 May 10;62(5):614-619. doi: 10.2967/jnumed.120.245423. Epub 2020 Dec 31.
In this review we examine, in the context of the amyloid, tau, and neurodegeneration framework, the available evidence and potential alternatives on how to establish tau positivity (T+) for multiple tau-imaging tracers in order to reach a consensus on normal and abnormal tau imaging values that can be universally implemented in clinical research and therapeutic trials.
在这篇综述中,我们在淀粉样蛋白、tau 和神经退行性变框架的背景下,检查了如何为多种 tau 成像示踪剂建立 tau 阳性(T+)的现有证据和潜在替代方法,以便就可普遍应用于临床研究和治疗试验的正常和异常 tau 成像值达成共识。